Showing 4771-4780 of 10183 results for "".
- Cynosure Taps Consumer Products Vet Anne Gates for Its Board of Directorshttps://practicaldermatology.com/news/cynosure-taps-consumer-products-veteran-anne-gates-for-its-board-of-directors/2460525/Anne Gates, former President at MGA Entertainment and Executive Vice President and CFO of The Walt Disney Company's Consumer Products Division, has joined Cynosure’s board of directors and will chair the company's audit committee. "Anne brings with her a wealth o
- Evolus Loses Round 1 in Trade Battle with AbbVie's Allerganhttps://practicaldermatology.com/news/evolus-loses-round-1-in-trade-battle-with-abbvies-allergan/2460455/Evolus' and Daewoong Pharma's Jeuveau lost the first round in a trade dispute with AbbVie's Allergan and its Korean partner Medytox that sought to block imports of the Botox rival, but the match is not over yet. AbbVie's Allergan and its Korean partner Medytox
- Prescriber’s Choice Launches “PC Direct” and “PC Delivers”https://practicaldermatology.com/news/prescribers-choice-launches-pc-direct-and-pc-delivers/2460362/Two new options from Prescriber’s Choice enable physicians to prescribe and ship medicines directly to patients for the treatment of dozens of dermatologic conditions. The ability to ship Prescriber’s Choice medicines to patients is an alternative to existing in-office dispensing to s
- DermWire Exclusive: Meet Allē, Allergan’s Upgraded Patient Loyalty Programhttps://practicaldermatology.com/news/dermwire-exclusive-meet-alle-allergans-upgraded-patient-loyalty-program/2460244/Allergan’s Brilliant Distinctions customer loyalty program is getting a facelift in honor of its 2nd decade. The program is smarter, faster and now goes by Allē. It’s much more than a new name, shares Carrie Strom, Allergan’s Senior Vice President o
- Allergan Acquires Envy Medical, Inc.https://practicaldermatology.com/news/allergan-acquires-envy-medical-inc/2459957/Allergan now owns Envy Medical, Inc. The acquisition adds Envy's Dermalinfusion, a non-surgical, non-invasive skin resurfacing system for the face and body, to Allergan's portfolio. Offered in physician's offices, medical spas and l
- RepliCel's Baldness Cure Performs Well In First In-Human Trialhttps://practicaldermatology.com/news/replicels-baldness-cure-performs-well-in-first-in-human-trial/2458246/The first in-human study of RepliCel Life Sciences Inc’s investigational baldness cure, RCH-01, confirms the therapy’s safety and demonstrates strong efficacy signals, the company reports. The autologous cell therapy involves culturing a person’s own dermal sheath cup ce
- Valeant Terminates European Licensing Rights for Brodalumabhttps://practicaldermatology.com/news/valeant-terminates-european-licensing-rights-for-brodalumab/2458512/Valeant Pharmaceuticals International, Inc.'s affiliate and AstraZeneca have amended Valeant's license for brodalumab, an IL-17 receptor monoclonal antibody under regulatory review for patients with moderate-to-severe plaque psoriasis, to terminate Valeant's right to develop and comme
- Biosimilar Update: Fresenius Kabi’s Idacio Joins Growing List of Available Humira Biosimilarshttps://practicaldermatology.com/news/biosimilar-update-fresenius-kabis-idacio-joins-growing-list-of-available-humira-biosimilars/2461836/Fresenius Kabi’s citrate-free adalimumab biosimilar
- DefenAge's D2-Minute Reveal Masque Named NewBeauty's 2019 Best Brightening Maskhttps://practicaldermatology.com/news/defenages-d2-minute-reveal-masque-named-newbeautys-2019-best-brightening-mask/2459973/DefenAge’s D2-Minute Reveal Masque is the
- FDA Advisory Arm Backs XELJANZ for PsAhttps://practicaldermatology.com/news/fda-advisory-arm-backs-xeljanz-for-psa/2458098/The United States Food and Drug Administration’s (FDA) Arthritis Advisory Committee recommends the approval of Pfizer's XELJANZ® (tofacitinib) for the treatment of adults with active psoriatic arthritis (PsA). The Arthritis Advisory Commit